Our current portfolio of stocks has done very well, thanks in part to the stock market’s healthy uptrend, but once again it’s time for a new stock. This month’s recommendation is a small company targeting the large and fast-growing field of hip and knee surgery, where demand for implants is expected to skyrocket in the years ahead, thanks to aging baby-boomers. Details in the issue.
